Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06258902
What this trial is testing

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

Who this might be right for
Pregnancy Related
Ipsen 20
Testing effectiveness (Phase 2)Study completedNCT00001239
What this trial is testing

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 100
Not applicableStudy completedNCT05184257
What this trial is testing

Zoladex® 10.8 BC RWS

Who this might be right for
Breast Cancer
AstraZeneca 1,176
Large-scale testing (Phase 3)Study completedNCT00459771
What this trial is testing

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 210
Not applicableUnknownNCT01336257
What this trial is testing

Effectiveness of a Decision Support System in Improving the Diagnosis and Screening Rate of Breast Cancer

Who this might be right for
Breast Cancer
Hospital Italiano de Buenos Aires 2,200
Testing effectiveness (Phase 2)Study completedNCT01730612
What this trial is testing

ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA

Who this might be right for
HER2 Negative Breast Carcinoma Expressing CEA
Nantes University Hospital 23
Not applicableStudy completedNCT03214419
What this trial is testing

Study First Step to Virtual Breast Cancer Localization

Who this might be right for
Breast Cancer
University Hospital, Montpellier 10
Not applicableStudy completedNCT05022511
What this trial is testing

Three Birds With One Stone

Who this might be right for
Uterine Cervical CancerUterine Cervix CancerUterine Cervical Neoplasm+5 more
University of Aarhus 27,099
Not applicableActive Not RecruitingNCT06522971
What this trial is testing

Effects of Physical Exercise on Response to Treatement in Breast Cancer

Who this might be right for
Breast Cancer
Latvian Biomedical Research and Study Centre 55
Testing effectiveness (Phase 2)Study completedNCT02876302
What this trial is testing

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer (IBC)
Dana-Farber Cancer Institute 23
Very early researchWithdrawnNCT01302002
What this trial is testing

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Who this might be right for
Breast Cancer
Instituto Nacional de Cancer, Brazil
Not applicableEnded earlyNCT01187381
What this trial is testing

An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 250
Testing effectiveness (Phase 2)UnknownNCT05134519
What this trial is testing

RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Xijing Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Not applicableStudy completedNCT03319511
What this trial is testing

Thoracic Spinal Anesthesia in Awake Breast Surgery

Who this might be right for
Breast Cancer
Alaa Mazy 70
Not applicableNot Yet RecruitingNCT07553234
What this trial is testing

Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment

Who this might be right for
Breast Cancer
University of Chicago 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07093931
What this trial is testing

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 468
Not applicableLooking for participantsNCT07225153
What this trial is testing

Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Analysis

Who this might be right for
Malnutrition (Calorie)Infant Nutrition DisorderGrowth Flatering+2 more
Aga Khan University 15
Not applicableStudy completedNCT02535637
What this trial is testing

Breastfeeding and Obesity on Offspring Body Composition

Who this might be right for
ObesityBreast Milk Collection
University of Oklahoma 37
Not applicableActive Not RecruitingNCT03255577
What this trial is testing

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast Cancer
Memorial Sloan Kettering Cancer Center 162
Next Page